7 studies found for:    16857991 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase III Study of Hemospan® to Prevent Hypotension in Hip Arthroplasty
Conditions: Hypotension;   Ischemia
Interventions: Drug: Hemospan (MP4OX);   Drug: Voluven (HES 130/0.4)
2 Withdrawn Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis
Conditions: Anemia, Sickle Cell;   Sickle Cell Anemia;   Sickle Cell Disease;   Sickle Cell Disorders;   Hemoglobin SC Disease;   Sickle Cell Hemoglobin C Disease
Interventions: Drug: MP4CO;   Drug: Sodium chloride solution
3 Withdrawn Phase 2c Dose Comparison Study of MP4OX in Trauma
Conditions: Trauma;   Hemorrhagic Shock;   Lactic Acidosis
Interventions: Drug: MP4OX;   Drug: Control
4 Completed Safety Study of Hemospan® in Prostatectomy Patients
Conditions: Blood Loss, Surgical;   Prostate Cancer;   Surgery
Interventions: Drug: Hemospan (MP4OX);   Drug: Ringer's lactate
5 Completed Phase III Study of Hemospan® for Treating Hypotension in Hip Arthroplasty
Conditions: Hypotension;   Ischemia
Interventions: Drug: Hemospan (MP4OX);   Drug: Voluven (HES 130/0.4)
6 Completed Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Conditions: Shock, Hemorrhagic;   Shock, Traumatic;   Acidosis, Lactic
Interventions: Drug: MP4OX;   Drug: Saline
7 Completed Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Conditions: Shock, Hemorrhagic;   Shock, Traumatic;   Acidosis, Lactic
Interventions: Drug: MP4OX;   Drug: Ringers Lactate solution

Indicates status has not been verified in more than two years